MedTech Acquisition Total Revenue

The latest total revenue for MTAC is $45M as of June 2026. That compares with $36M in the prior-year period — up 25.2% year over year. That is below the sector sector average of $1.3B. Investors often review this figure alongside MedTech Acquisition's historical trend and sector peers before judging valuation or financial health.

Over the past year, MTAC's total revenue moved from $36M to $45M — a 25.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MedTech Acquisition's operating scale or balance-sheet position.

Against its sector companies, MTAC currently prints $45M for total revenue, while the sector average sits near $1.3B. That is roughly 96.6% below the sector mean. Large gaps often invite a closer look at MedTech Acquisition's growth, margins, and balance sheet.

A total revenue figure of $45M for MTAC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $1.3B. Explore the charts below for those layers of context.

After noting MTAC's total revenue ($45M), review year-over-year change from $36M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.